We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

29 hedge funds and large institutions have $2.55M invested in TriSalus Life Sciences Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 30 → 29 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

66% less capital invested

Capital invested by funds: $7.44M → $2.55M (-$4.89M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
2
Calls
$475K
Puts
–
Net Calls
+$475K
Net Calls Change
+$4K

Top Buyers

1
AGM
Alpine Global Management
New York
+$829
2
OMC
Old Mission Capital
Illinois
+$43

Top Sellers

1
MP
Mangrove Partners
Connecticut
-$4.92M
2
MF
Magnetar Financial
Illinois
-$1.26K
3
MC
Meteora Capital
Florida
-$1K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$194
5
UBS Group
UBS Group
Switzerland
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.37M – – –
AGC
2
Angelo Gordon & Co
New York
$951K – – –
MF
3
Magnetar Financial
Illinois
$73K -$1.26K -17,589 -1%
DM
4
Deerfield Management
New York
$20K – – –
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$17K – – –
CS
6
Clear Street
New York
$15K – – –
IM
7
Islet Management
New York
$10K – – –
KL
8
KIM LLC
Kansas
$10K – – –
KC
9
Kepos Capital
New York
$9K – – –
VI
10
Vestcor Inc
New Brunswick, Canada
$9K – – –
MP
11
MSD Partners
New York
$8K – – –
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$8K – – –
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$6K – – –
BCL
14
Bracebridge Capital LLC
Massachusetts
$6K – – –
Walleye Capital
15
Walleye Capital
New York
$6K – – –
SCM
16
Shaolin Capital Management
Florida
$5K – – –
AA
17
AQR Arbitrage
Connecticut
$4K – – –
CCM
18
Context Capital Management
California
$4K – – –
ZCA
19
Zeke Capital Advisors
Pennsylvania
$4K – – –
BCM
20
Basso Capital Management
Connecticut
$3K – – –
CM
21
CastleKnight Management
New York
$3K – – –
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$1K -$194 -2,707 -12%
Jane Street
23
Jane Street
New York
$1K – – –
Nomura Holdings
24
Nomura Holdings
Japan
$1K – – –
OCAM
25
Owl Creek Asset Management
New York
$1K – – –
1
2

TLSIW Hedge Fund Activity: Q3 2022 in Review

29 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2022, worth a combined $2.55M — down 66% from $7.44M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TLSIW and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Alpine Global Management, opening a new position worth an estimated $829. The largest seller was Mangrove Partners, exiting entirely with an estimated $4.92M sold.

  • 29 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2022, down from 30 in Q2 2022.
  • Funds reported $2.55M of TriSalus Life Sciences Warrant stock for Q3 2022, down 66% quarter-over-quarter.
  • 1 fund opened new TriSalus Life Sciences Warrant positions in Q3 2022 and 2 closed out, a net change of -1 holder.
  • The largest TriSalus Life Sciences Warrant buyer in Q3 2022 was Alpine Global Management, an estimated $829 added.
  • The largest TriSalus Life Sciences Warrant seller in Q3 2022 was Mangrove Partners, an estimated $4.92M sold.

Based on aggregated 13F filings for Q3 2022.